Search

About Dr. Pradeep Kumar Thapa

Dr. Pradeep Thapa is a Senior Consultant in Nuclear Medicine with over 12 years of professional experience in nuclear medicine diagnostics and radionuclide therapy. His expertise encompasses advanced imaging techniques and therapeutic applications of nuclear medicine.

He completed his MBBS from T.N. Medical College, Mumbai, followed by a Diploma in Radiation Medicine (DRM) from the Institute of Nuclear Medicine and Allied Sciences, Delhi University. He subsequently completed his DNB in Nuclear Medicine from Radiation Medicine Centre, Mumbai, and earned the Fellowship of the European Board of Nuclear Medicine (FEBNM).

Dr. Thapa has extensive experience with PET-CT, SPECT-CT, Gamma Camera imaging, and advanced PET tracers, including Ga-68 DOTANOC and Ga-68 PSMA. His therapeutic expertise includes radionuclide therapies using Lutetium-177, Iodine-131, Samarium-153, and Iodine-131 MIBG for various oncological and non-oncological conditions.

His academic contributions include numerous national and international research publications, along with presentations at nuclear medicine conferences and forums.

Request an appointment with Dr. Pradeep Kumar Thapa

Share your details and our care team will confirm a slot for you.

Request a Call Back

Dr. Pradeep Kumar Thapa

Education

  • MBBS from TN Medical College, Mumbai Central, Mumbai -2007
  • DRM from Institute of Nuclear Medicine and Allied Sciences, Delhi University – 2010- 2012
  • DNB Nuclear medicine, Radiation Medicine Centre, Mumbai – 2013-2015
  • Fellow European Board of Nuclear Medicine (FEBNM) – October 2018
     

Training & certificates

  • Fellowship of the European Board of Nuclear Medicine (FEBNM) – October 2018
  • Diploma in Radiation Medicine (DRM) – Institute of Nuclear Medicine and Allied Sciences, Delhi University
  • DNB in Nuclear Medicine – Radiation Medicine Centre, Mumbai

Special areas of interest

  • PET-CT & SPECT-CT
  • Gamma Camera Imaging
  • Nuclear Medicine Diagnostics
  • Thyroid Disorders & Radioiodine Therapy
  • Ga-68 DOTANOC & Ga-68 PSMA Imaging
  • Peptide Receptor Radionuclide Therapy (PRRT)
  • Lutetium-177 PSMA Therapy
  • Radionuclide Therapy
  • Bone Pain Palliation
  • I-131 MIBG Therapy
  • Nuclear Medicine Oncology
  • Alavi-Mandell Award – For the publication “Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases”
  • Best Poster Award – For “Comparative Study Between Tc-99m Methionine and C-11 Methionine in Detection of Recurrence in Primary Brain Tumor” at the Annual Conference of the Society of Nuclear Medicine, India (2011)
  • Thapa P, Basu S. Leveraging the power of non-radium radionuclide treatments in bone metastases. Q J Nucl Med Mol Imaging. 2019 Jul 1.
  • Basu S, Chakraborty S, Parghane RV, Kamaldeep, Ranade R, Thapa P. One decade of ‘Bench-to-Bedside’ peptide receptor radionuclide therapy with indigenous [ 177 Lu] Lu-DOTATATE obtained through ‘Direct’ neutron activation route: lessons learnt including practice evolution in an Indian setting. Am J Nucl Med Mol Imaging. 2020 Aug 25;10(4):178-211.
  • Thapa P, Kalshetty A, Basu S. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary: A subgroup-specific analysis based on clinical presentation. World J Nucl Med. 17(4):219-222. Oct-Dec 2017.
  • Dutta D, Pandey RK, Gogoi R, Solanki N, Madan R, Mondal A, Dogra S, Thapa P. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia – diagnostic challenges and clinical outcomes. Endokrynol Pol. 69(2):205-210. 2018.
  • Thapa P, Parghane R, Basu S. 177-Lu DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites. World J Nucl Med. 16(3):223-228. Jul-Sep 2017.
  • Member of European Association of Nuclear Medicine.
  • Member of Society of Nuclear Medicine, India.

Best Oncology Doctors

View all →
Fee Monday To Saturday 9:00 AM – 5:00 PM
Call Book
Enquiry Now